AI assistant
Sending…
Aqua Bio Technology — Director's Dealing 2024
Jan 30, 2024
3535_rns_2024-01-30_c819722b-5a8c-4738-8657-ba0f667a464d.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Notification and public disclosure of transactions by Primary Insiders and their Close Associates
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Per Egil Borge | ||
| 2 | Reason for the notification | |||
| a) | Position/status | Chairman of the board of wholly owned subsidiary, Skinteam Norge AS |
||
| b) | Initial notification/ | Initial notification | ||
| Amendment | ||||
| 3 | Details of the issuer | |||
| a) | Name | Aqua Bio Technology ASA | ||
| b) | LEI | 529900RG33DF0N88RJ88 | ||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
| a) | Description of the financial instrument, type of instrument Identification code |
Shares in Aqua Bio Technology ASA, with ISIN NO0010307135 | ||
| b) | Nature of the transaction | Subscription of shares in private placement | ||
| c) | Price(s) and volume(s) | |||
| Price(s) | Volume(s) | |||
| 5 | 78,000 | |||
| d) | Aggregated information | |||
| - Aggregated volume |
78,000 | |||
| - Price |
390,000 | |||
| e) | Date of the transaction | 30 January 2024 | ||
| f) | Place of the transaction | Outside a trading venue |
More from Aqua Bio Technology
Proxy Solicitation & Information Statement
2026
May 27
Proxy Solicitation & Information Statement
2026
May 27
Proxy Solicitation & Information Statement
2026
May 27
Report Publication Announcement
2026
May 27
Report Publication Announcement
2026
Apr 27
Share Issue/Capital Change
2026
Apr 21
Report Publication Announcement
2026
Apr 21
Report Publication Announcement
2026
Apr 21
Capital/Financing Update
2026
Apr 10
Capital/Financing Update
2026
Apr 10